Amylin/GLP-1Phase 3
Amycretin
Amycretin (investigational)
Studied for
- Weight loss
- Type 2 diabetes
Subcutaneous injection and oral tablet (both in development) · Once weekly (injectable); once daily (oral)
Investigational. No FDA-approved purchase option.